2017
Feasibility, acceptability, tolerability of targeted naltrexone for non-dependent methamphetamine – Using and binge-drinking men who have sex with men
Santos G, Coffin P, Santos D, Huffaker S, Matheson T, Euren J, DeMartini A, Rowe C, Hahn J, Vlahov D, Vittinghoff E, Batki S. Feasibility, acceptability, tolerability of targeted naltrexone for non-dependent methamphetamine – Using and binge-drinking men who have sex with men. Drug And Alcohol Dependence 2017, 171: e183. DOI: 10.1016/j.drugalcdep.2016.08.502.Peer-Reviewed Original Research
2002
Sex-Specific Differences in Circumstances of Initiation into Injecting-Drug Use Among Young Adult Latinos in Harlem, New York City
Diaz T, Vlahov D, Edwards V, Conover S, Monterroso E. Sex-Specific Differences in Circumstances of Initiation into Injecting-Drug Use Among Young Adult Latinos in Harlem, New York City. AIDS And Behavior 2002, 6: 117-122. DOI: 10.1023/a:1015441030030.Peer-Reviewed Original ResearchInjecting Drug UsersInjecting-drug useCircumstances of initiationSexual partnersDrug useFirst injection episodeInjecting Drug UseRecent risk behaviorsCohort studyHIV infectionYoung adult LatinosMedian numberSex-specific differencesUnprotected sexPrevention programsAdult LatinosRisk behaviorsNew York CityHIVMore womenWomenBaseline dataStandardized faceMenInjection episodes
2000
HIV testing and retesting for men and women in Switzerland
Zwahlen M, Neuenschwander B, Jeannin A, Dubois-Arber F, Vlahov D. HIV testing and retesting for men and women in Switzerland. European Journal Of Epidemiology 2000, 16: 123-133. PMID: 10845261, DOI: 10.1023/a:1007638823567.Peer-Reviewed Original Research
1999
Sex Differences in Longitudinal Human Immunodeficiency Virus Type 1 RNA Levels among Seroconverters
Sterling T, Lyles C, Vlahov D, Astemborski J, Margolick J, Quinn T. Sex Differences in Longitudinal Human Immunodeficiency Virus Type 1 RNA Levels among Seroconverters. The Journal Of Infectious Diseases 1999, 180: 666-672. PMID: 10438353, DOI: 10.1086/314967.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virus type 1 RNA levelsHIV-1 seroconvertersSex differencesCopies/mLHIV-1 pathogenesisInjection drug usersCase-control studyTime of seroconversionCross-sectional studyCourse of infectionMale patientsRapid progressorsFemale patientsCopies/Drug usersMale controlsVirus levelsPatientsRNA levelsSeroconvertersWomenMenNonprogressorsSeroconversionProgressors
1997
Syphilis in injecting drug users: clues for high-risk sexual behaviour in female IDUs
Muga R, Roca J, Tor J, Pigem C, Rodriguez R, Egea J, Vlahov D, Muñoz A. Syphilis in injecting drug users: clues for high-risk sexual behaviour in female IDUs. International Journal Of STD & AIDS 1997, 8: 225-228. PMID: 9147154, DOI: 10.1258/0956462971919967.Peer-Reviewed Original ResearchConceptsHuman immunodeficiency virusRapid plasma reagentEnzyme-linked immunosorbent assaySerologic syphilisDrug usersSex partnersHigh-risk sexual behaviorCross-sectional analysisGender-specific differencesMale IDUsHIV infectionImmunodeficiency virusFemale IDUsSexual transmissionTreponemal testsReactive samplesSyphilisSexual partnersWestern blotImmunosorbent assayIDUsPlasma reagentWomenSexual behaviorMen
1996
Evidence for HIV Type 1 Strains of U.S. Intravenous Drug Users as Founders of AIDS Epidemic among Intravenous Drug Users in Northern Europe
Lukashov V, Kuiken C, Vlahov D, Coutinho R, Goudsmit J. Evidence for HIV Type 1 Strains of U.S. Intravenous Drug Users as Founders of AIDS Epidemic among Intravenous Drug Users in Northern Europe. AIDS Research And Human Retroviruses 1996, 12: 1179-1183. PMID: 8844022, DOI: 10.1089/aid.1996.12.1179.Peer-Reviewed Original ResearchConceptsIntravenous drug usersHomosexual menDrug usersV3 sequencesEuropean intravenous drug usersHIV Type 1 StrainsAIDS epidemicHIV-1 epidemicGp120 V3 loopSignature pattern analysisType 1 strainsRisk groupsV3 loopEpidemiological linkMenEpidemicVirusUnited StatesSuggestive evidencePresent suggestive evidenceHigh levelsNucleotide substitutionsEuropean originRE: “DETERMINANTS OF HIV DISEASE PROGRESSION AMONG HOMOSEXUAL MEN REGISTERED IN THE TRICONTINENTAL SEROCONVERTER STUDY” AND “PROGRESSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION AMONG HOMOSEXUAL MEN IN HEPATITIS B VACCINE TRIAL COHORTS IN AMSTERDAM, NEW YORK CITY, AND SAN FRANCISCO, 1978–1991”
Zwahlen M, Vlahov D, Hoover D. RE: “DETERMINANTS OF HIV DISEASE PROGRESSION AMONG HOMOSEXUAL MEN REGISTERED IN THE TRICONTINENTAL SEROCONVERTER STUDY” AND “PROGRESSION OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION AMONG HOMOSEXUAL MEN IN HEPATITIS B VACCINE TRIAL COHORTS IN AMSTERDAM, NEW YORK CITY, AND SAN FRANCISCO, 1978–1991”. American Journal Of Epidemiology 1996, 143: 523-525. PMID: 8610669, DOI: 10.1093/oxfordjournals.aje.a008775.Peer-Reviewed Original Research
1995
Changes in Markers of Disease Progression in HIV-1 Seroconverters
Galai N, Vlahov D, Margolick J, Chen K, Graham N, Munoz A. Changes in Markers of Disease Progression in HIV-1 Seroconverters. JAIDS Journal Of Acquired Immune Deficiency Syndromes 1995, 8: 66-82. PMID: 8548349, DOI: 10.1097/00042560-199501000-00011.Peer-Reviewed Original ResearchConceptsHomosexual menDrug usersDisease progressionRisk groupsHuman immunodeficiency virus (HIV) disease progressionHIV-1 seroconversionHIV-1 seroconvertersT lymphocyte subsetsImmune deficiency syndromeWhite homosexual menCD8 percentagesTotal lymphocytesHIV infectionSimilar CD4HIV seroconvertersDeficiency syndromeInitial courseSeroconversionCD4Long incubation periodSeroconvertersMenCohortInfectionSimilar rates
1994
Epidemiology of Hepatitis B Virus Infections among Injecting Drug Users: Seroprevalence, Risk Factors, and Viral Interactions
Levine O, Vlahov D, Nelson K. Epidemiology of Hepatitis B Virus Infections among Injecting Drug Users: Seroprevalence, Risk Factors, and Viral Interactions. Epidemiologic Reviews 1994, 16: 418-436. PMID: 7713187, DOI: 10.1093/oxfordjournals.epirev.a036161.Peer-Reviewed Original Research
1991
Prevalence of Antibody to HIV-1 Among Entrants to US Correctional Facilities
Vlahov D, Brewer T, Castro K, Narkunas J, Salive M, Ullrich J, Muñoz A. Prevalence of Antibody to HIV-1 Among Entrants to US Correctional Facilities. JAMA 1991, 265: 1129-1132. PMID: 1995998, DOI: 10.1001/jama.1991.03460090077036.Peer-Reviewed Original ResearchConceptsPrevalence of antibodiesHuman immunodeficiency virus type 1Immunodeficiency virus type 1HIV-1 prevalenceHIV-1 seroprevalenceAge 25 yearsVirus type 1US correctional facilitiesConsecutive malesHIV-1Older womenOlder menPrevention programsType 1Young womenPrevalenceWomenCorrectional systemYoung menMenSeroprevalenceAntibodiesProgram planningCorrectional facilities